Insmed Inc (INSM)

[surf_baron]

Did not suggest you made numbers up, that's why I sent the link.... Lots of preemies have eye issues from ROP that weren't seious enough for surgery. Surgery is performed in most severe cases to prevent retinal detachment and blindness. My whole point is there is a market here for INSM to pursue orphan status for. Without clinicals no one will know for sure, that's part of my point. Another group has apparently already been given orphan status in Europe. Many bio players are successful in niche/orphan indications and markets, some have even made a business model out of it. So where's INSM in this market, are they involved with these studies and will ultimately get this orphan indication?